1. Introduction {#sec1-ijerph-15-00912}
===============

Peptic ulcer disease (PUD) is a disease located in the gastric or duodenal part of the gastrointestinal tract that mainly involves the mucosa layer. The two main risk factors for PUD are *Helicobactor pylori* (*H. pylori*) infection and medication consumption, especially of nonsteroid anti-inflammatory drugs (NSAIDs) \[[@B1-ijerph-15-00912]\]. The prevalence of PUD ranges from 0.12 to 1.5% and increases with age \[[@B2-ijerph-15-00912]\]. The major symptom of uncomplicated PUD is upper abdominal dyspepsia such as bloating, early satiety, and nausea \[[@B3-ijerph-15-00912]\].

Periodontitis (PD) is defined as an inflammatory disease of the supporting tissues surrounding the teeth \[[@B4-ijerph-15-00912]\]. Inflammatory periodontal disease results from a complex interaction between the subgingival biofilm and the host immune--inflammatory events \[[@B5-ijerph-15-00912]\]. In response to the challenge presented by the bacteria, progressive destruction in the gingival and periodontal tissues occurs. A four-year national survey in the U.S. showed that 46% of adults aged ≥30 years had PD, with 8.9% having severe PD. Asian Americans experienced a mean attachment loss of 1.95 mm and 15.4% had clinical attachment loss (CAL) ≥7 mm \[[@B6-ijerph-15-00912]\]. In addition, a study of PD prevalence in Taiwan showed that the prevalence of PD gradually rose from 11.5% in 1997 to 19.59% in 2013 during the 17-year study period \[[@B7-ijerph-15-00912]\].

*H. pylori* infection plays a crucial role in the pathogenesis of PUD. *H. pylori* infection is involved in various gastroduodenal pathologies, and evokes the production of proinflammatory interleukin-1beta \[[@B8-ijerph-15-00912]\], leading to the reduction of blood flow to the gastroduodenal tract and increasing the risk of peptic ulcers \[[@B9-ijerph-15-00912]\]. *H. pylori* can colonize not only in the stomach, but also in the oral cavity. The oral cavity may be a reservoir for *H. pylori* and a potential source for infection of the stomach \[[@B10-ijerph-15-00912]\]. Previous studies have provided evidence that PUD might be associated with PD \[[@B11-ijerph-15-00912],[@B12-ijerph-15-00912],[@B13-ijerph-15-00912],[@B14-ijerph-15-00912]\]; however, no clear conclusions have been reached thus far. Therefore, we conducted a population-based case-control study to investigate the putative association from the database of Taiwanese National Health Insurance Research (NHIRD).

2. Materials and Methods {#sec2-ijerph-15-00912}
========================

2.1. Data Source and Study Design {#sec2dot1-ijerph-15-00912}
---------------------------------

The dataset used in this case-control study was derived from the NHIRD in Taiwan. The Longitudinal Health Insurance Database 2010 (LHID2010) was created and released to the public by the National Health Research Institute (NHRI) and includes all the original claims data and registration files from 2000 to 2013 for one million individuals randomly sampled from the Registry for Beneficiaries of the National Health Institute (NHI) program in 2010 in Taiwan. There are approximately 27.38 million individuals on this registry, with a coverage rate of more than 99%. The disease diagnoses were defined according to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). This study was approved by the Chung Shan Medical University Hospital Ethics Review Board (CSMUH No.CS2-15017, Date: 10/04/2015).

2.2. Selection of Case and Control {#sec2dot2-ijerph-15-00912}
----------------------------------

We used the ICD-9-CM diagnosis codes to identify the subjects with PUD. Gastric ulcers (ICD-9-CM code 531), duodenal ulcers (ICD-9-CM codes 532), and peptic ulcers (ICD-9-CM codes 533) occurring between January 2000 and December 2013 were retrieved from the database. Patients aged under 18 years old, aged older than 65 years old, who had withdrawn from the program, or for whom data were missing were excluded from this study. Patients who had a past history of stomach surgery, gastric cancer, or Zollinger--Ellison syndrome were also excluded. Cases were selected under a minimum of three diagnoses of PUD (ICD-9-CM codes: 531, 532, 533) after outpatient department visits. For each case, we conditionally selected comparison subjects from the general population with matched gender, age, urbanization level, socioeconomic status, and Charlson comorbidity index (CCI) \[[@B15-ijerph-15-00912]\] by using a propensity score method at a 1:1 ratio. Urbanization was categorized into three levels---urban, suburban, and rural areas---based on the classification scheme proposed by Liu et al. \[[@B16-ijerph-15-00912]\]. Socioeconomic status was defined by monthly income (\<NT\$ 20,000, NT\$ 20,000--40,000, and \>NT\$ 40,000). The Charlson Comorbidity Index (CCI) was used to estimate the overall systemic health. Each increment in the CCI score indicates a stepwise increase in cumulative mortality.

2.3. Exposure Assessment {#sec2dot3-ijerph-15-00912}
------------------------

To validate the PD diagnosis sourced from the administrative database, we identified PD cases not just by the ICD-9-CM diagnosis codes (ICD-9-CM codes 523.3, 523.4, and 523.5), but also by the treatment codes (91006C, 91007C, 91008C 91009B, and 91010B) of the NHI system. The periodontal treatment code including subgingival curettage and periodontal flap operation is described in [Table 1](#ijerph-15-00912-t001){ref-type="table"}. The NHI system allows dental clinicians to perform periodontal treatment only if beneficiaries meet the criteria as prescribed. Potential confounding factors including sex, age, socioeconomic factors, urbanization, and CCI were identified and categorized. The flowchart of the study is shown in [Figure 1](#ijerph-15-00912-f001){ref-type="fig"}.

2.4. Statistical Analysis {#sec2dot4-ijerph-15-00912}
-------------------------

Statistical analyses were performed using Student's *t*-test for continuous variables and the chi-squared test for categorical variables. The odds ratio (OR) between the case and control groups was analyzed with the chi-square test. A multinomial logistic regression model was used for subgroup analysis. All results are presented in ORs and 95% confidence intervals (CIs). A two-sided *p* \< 0.05 was considered statistically significant. All analyses were conducted in SPSS version 22 (SPSS Inc., Chicago, IL, USA).

3. Results {#sec3-ijerph-15-00912}
==========

As shown in [Table 2](#ijerph-15-00912-t002){ref-type="table"}, 177,240 cases and 177,240 control patients were included in this study, with an average age of 46.96 $\pm$ 11.76 years. In the case group, 81,965 (46.25%) cases were male and 95,275 (53.75%) were female. Characteristics including age, gender, urbanization, monthly income, and CCI score were not significantly different between the 1:1 matched cases and the control group (*p* \> 0.05).

The risk of PUD for patients diagnosed with PD was 1.15-fold when compared with those without PD (OR, 1.15; 95% CI, 1.12--1.18) in [Table 3](#ijerph-15-00912-t003){ref-type="table"}.

4. Discussion {#sec4-ijerph-15-00912}
=============

In this case-control study, we revealed that PD was positively associated with PUD (OR, 1.15; 95% CI, 1.12--1.18). A significantly higher proportion with a diagnosis of PD was found among patients of PUD when compared with the control group.

PD is derived from a complex interaction between the subgingival biofilm and the host immune--inflammatory events. The net result of these inflammatory changes could break down the fibers of the periodontal ligament, leading to clinical loss of attachment, resorption of the alveolar bone with increased probing depth formation, and tooth loss \[[@B17-ijerph-15-00912]\]. Moreover, the chronic inflammation is associated with multiple systemic diseases including diabetes mellitus \[[@B18-ijerph-15-00912]\], rheumatoid arthritis \[[@B19-ijerph-15-00912]\], and cardiovascular disease \[[@B20-ijerph-15-00912]\]. In recent scientific research, few studies \[[@B11-ijerph-15-00912],[@B12-ijerph-15-00912],[@B13-ijerph-15-00912],[@B14-ijerph-15-00912],[@B21-ijerph-15-00912]\] have proposed the positive association between PD and PUD. Our investigation showed similar results. However, those studies recruited fewer participants and some studies \[[@B11-ijerph-15-00912],[@B14-ijerph-15-00912]\] used self-administered questionnaires for disease evaluation or were confined to a specific group like health professionals \[[@B11-ijerph-15-00912]\], which made the outcomes limited for interpretation.

This case-control study had more strength than the previous cross-sectional design of studies. To the best of our knowledge, this is the first large-scale population-based study to investigate the association between PD and PUD. With large numbers of participants derived from the NHIRD, the longitudinal sampling dataset from 2000 to 2013 made this study more representative. The selection of cases was on the basis of ICD-9 diagnostic codes plus the diagnoses of at least three outpatient department visits to improve the validity of our measurements. We also solidified the diagnosis of PD in corresponding periodontal treatment procedure. A well-matched case and control group can minimize the potential biases of gender, age, urbanization, socioeconomic status, and CCI.

Despite considerable debate surrounding the pathophysiology underlying the association between PD and PUD, the influence of PD on PUD could be explained in several ways. Two important risk factors for PUD are *H. pylori* infection and NSAID use. *H. pylori* is a Gram-negative bacterium that colonizes mainly in the gastric mucosa and its presence has been universally associated with chronic gastritis, peptic ulcers, and mucosa-associated lymphoid tissue lymphoma \[[@B3-ijerph-15-00912],[@B22-ijerph-15-00912]\]. The maintenance of gastrointestinal tract hormones plays a fundamental role in the regulation of body physiological activity; however, *H. pylori* infection might cause an imbalance of hormones \[[@B23-ijerph-15-00912],[@B24-ijerph-15-00912],[@B25-ijerph-15-00912]\]. The prevalence of *H. pylori* infection is high and is more than 50% in most countries worldwide \[[@B26-ijerph-15-00912]\]. Many studies have mentioned that the periodontal reservoir harvested *H. pylori* and caused inflammation, which induced PD \[[@B27-ijerph-15-00912],[@B28-ijerph-15-00912],[@B29-ijerph-15-00912]\]. Some studies have shown that the presence of *H. pylori* in dental plaque via different detection methods might be a possible source of infection and reinfection of the stomach \[[@B21-ijerph-15-00912],[@B30-ijerph-15-00912],[@B31-ijerph-15-00912],[@B32-ijerph-15-00912]\]. In summary, these works have shown the positive association between *H. pylori* and periodontal pathogens. Other studies have also discussed the effects of periodontal therapy on oral and gastric *H. pylori* \[[@B30-ijerph-15-00912],[@B33-ijerph-15-00912],[@B34-ijerph-15-00912]\]. Those who received both anti-*H. pylori* and periodontal therapy had higher eradication rates when compared with those who only received anti-*H. pylori* therapy \[[@B30-ijerph-15-00912],[@B33-ijerph-15-00912]\]. In addition, a meta-analysis suggested that periodontal therapy could improve the outcome of eradication therapy of PUD \[[@B34-ijerph-15-00912]\].

Due to our strict assessment of PD from NHIRD by using both ICD-9 diagnostic codes and treatment codes, patients with a diagnosis of PD corresponded to a proper periodontal treatment. It must be emphasized that the strict assessment of exposure caused a low prevalence rate of PD in this study. Although it did not reach a statistically significant difference between the surgical and nonsurgical periodontal treatment procedures in the stratified analysis, it seemed that the ORs of PUD were attenuated with the intensity of treatment. Periodontal treatment that includes surgical and nonsurgical periodontal therapy along with patient education for plaque control could eradicate the oral *H. pylori*. The reduction in microbial etiological factors after periodontal treatment might lead to a reduced risk of PUD. Recently, a review of periodontium and *H. pylori* supported the view that periodontal treatment may play an effective role in the management of *H. pylori*-associated gastric disease \[[@B35-ijerph-15-00912]\]. Further analyses to clarify the impact of the intensity of periodontal therapy still need to be carried out.

It has been reported that both PD and PUD are associated with low socioeconomic status \[[@B36-ijerph-15-00912],[@B37-ijerph-15-00912],[@B38-ijerph-15-00912],[@B39-ijerph-15-00912]\]. In our study, approximately 78% of patients were considered to be socioeconomically disadvantaged due to a low monthly income (\<NT\$ 20,000). In spite of increasing trends of poorer health among those with a lower socioeconomic status, there are still some risk factors that are unevenly distributed across socioeconomic status, such as smoking habits \[[@B40-ijerph-15-00912]\]. One major limitation of our study retrieved from the NHIRD was the lack of anthropometric data and health-related behaviors or status such as betel nut chewing habit, cigarette smoking, and alcohol consumption. This limitation is caused by the inherent shortcomings of the administrative database. Nevertheless, the use of a nationwide population-based database can provide sufficient sample size, generalizability, and statistical power to assess the association of diseases. It may be beneficial to provide additional data analysis and assist in planning treatment strategies.

5. Conclusions {#sec5-ijerph-15-00912}
==============

In conclusion, this study demonstrated a positive association between PUD and PD. The results showed the clinical value for both dental and gastroenterological practitioners, suggesting a newer treatment consideration for PUD. However, further prospective studies are needed to confirm the causal relationship between these two diseases.
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###### 

Periodontal treatment code of the NHI system.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Coding        Periodontitis Treatment                                               Description
  ------------- --------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------
  Nonsurgical                                                                         

  91006C        Subgingival curettage (Root planing)---full mouth                     \* At least 1 pocket depth ≥5 mm of 6 probing sites in one tooth.\
                                                                                      \* Records of pocket depth and X-ray prior to treatment are needed.\
                                                                                      \* Procedure is allowed in dental clinics, local community hospitals, metropolitan hospitals, and medical centers.

  91007C        Subgingival curettage (Root planing)---1/2 arch                       

  91008C        Subgingival curettage (Root planing)---localized, less than 3 teeth   

  Surgical                                                                            

  91009B        Periodontal flap operation---localized, less than 3 teeth             \*At least 1 pocket depth ≥5 mm of 6 probing sites in one tooth.\
                                                                                      \* Records of pocket depth and x-ray prior to treatment are needed.\
                                                                                      \* Procedure is allowed in local community hospitals, metropolitan hospitals, and medical centers.

  91010B        Periodontal flap operation---1/3 arch, 4 to 6 teeth                   
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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###### 

Comparisons in demographic characteristics in patients with PUD.

  Variable              Total (*n* = 354,480)   PUD (*n* = 177,240)   Non-PUD (*n* = 177,240)   *p*-Value                     
  --------------------- ----------------------- --------------------- ------------------------- ----------- --------- ------- ------
  Periodontitis         24,964                  7.04                  13,298                    7.5         11,666    6.58    
  Age (years)           46.96 ± 11.76           46.95 ± 11.75         46.96 ± 11.76             0.83                          
  Age groups (years)                                                                                                          0.72
  18--25                15,772                  4.45                  7885                      4.45        7887      4.45    
  26--35                53,348                  15.05                 26,670                    15.05       26,678    15.05   
  36--45                83,196                  23.47                 41,565                    23.45       41,631    23.49   
  46--55                98,874                  27.89                 49,615                    27.99       49,259    27.79   
  56--65                103,290                 29.14                 51,505                    29.06       51,785    29.22   
  Gender                                                                                                                      0.91
  Female                190,585                 53.76                 95,275                    53.75       95,310    53.77   
  Male                  163,895                 46.24                 81,965                    46.25       81,930    46.23   
  Urbanization                                                                                                                0.34
  Urban                 212,059                 59.82                 105,886                   59.74       106,173   59.9    
  Suburban              116,103                 32.75                 58,088                    32.77       58,015    32.73   
  Rural                 26,318                  7.42                  13,266                    7.48        13,052    7.36    
  Monthly income                                                                                                              0.89
  \<NT\$ 20,000         275,262                 77.65                 137,588                   77.63       137,674   77.68   
  NT\$ 20,000\~40,000   53,037                  14.96                 26,526                    14.97       26,511    14.96   
  \>NT\$ 40,000         26,181                  7.39                  13,126                    7.41        13,055    7.37    
  CCI                                                                                                                         0.11
  0                     194,648                 54.91                 97,318                    54.91       97,330    54.91   
  1                     79,339                  22.38                 39,464                    22.27       39,875    22.5    
  ≧2                    80,493                  22.71                 40,458                    22.83       40,035    22.59   

PUD: Peptic ulcer disease; CCI: Charlson comorbidity index.
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###### 

Odds ratio for peptic ulcer disease in those with a diagnosis of periodontitis.

                  PUD               Non-PUD           OR
  --------------- ----------------- ----------------- -------------------
  Periodontitis                                       
  No              163,942 (92.5%)   165,574 (93.4%)   1
  Yes             13,298 (7.5%)     11,666 (6.6%)     1.15 (1.12--1.18)

PUD: peptic ulcer disease; OR: odds ratio.
